OncoDNA announces screening collaboration with Kura Oncology
22 mai 2018 07h00 HE | Kura Oncology, Inc.
- OncoDNA to support patient enrolment for Kura Oncology’s Phase II trial of tipifarnib- Agreement demonstrates OncoDNA’s biopharma partnership strategy GOSSELIES, Belgium, May 22, 2018 (GLOBE...